Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
TOPIRAMATE
Medication labelWhy this: Advisory · dailymed-prescription
1.1 Monotherapy EpilepsyTopiramate tablets, USP are indicated as initial monotherapy in patients 2 years of age and older with partial onset or primary generalized tonic-clonic seizures. Safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials [see Clinical Studies (14.1)]. 1.2 Adjunctive Therapy EpilepsyTopiramate tablets, USP are indicated as adjunctive therapy for adults and pediatric patients ages 2 to 16 years with partial onset seizures or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with Lennox-Gastaut syndrome [see Clinical Studies (14.2)].
- generic_name
- topiramate
- product_names
- TOPIRAMATE
- ndc
- 61919-691, 31722-280, 61919-691-30, 61919-691-60
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en